Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Screening Europe - HTS & Compound Management

Larry Sklar's Biography



Larry Sklar, Director, University of New Mexico Health Sciences Center

Larry A. Sklar (Ph.D., Physical Chemistry, Stanford) is PI and Director of the University of New Mexico Center for Molecular Discovery. He is Regents Professor of Pathology and Distinguished University Professor as well as Associate Director, Drug Discovery, in the NCI Designated University of New Mexico Cancer Center and Co-Director of Translational Technology in the UNM Clinical and Translational Science Center. He has 350 publications and patents in leukocyte biology, molecular assembly in signal transduction and cell adhesion, as well as high throughput flow cytometry for drug discovery. He is co-inventor of the HyperCyt high throughput flow cytometry platform and co-founder of IntelliCyt.

Larry Sklar Image

High Throughput Flow Cytometry for Small Molecule Discovery in the NIH Molecular Libraries Initiative and Beyond

Friday, 1 July 2011 at 11:45

Add to Calendar ▼2011-07-01 11:45:002011-07-01 12:45:00Europe/LondonHigh Throughput Flow Cytometry for Small Molecule Discovery in the NIH Molecular Libraries Initiative and BeyondSELECTBIOenquiries@selectbiosciences.com

The University of New Mexico Center for Molecule Discovery (U54MH084690, http://screening.health.unm.edu/) identifies and implements novel applications of the HyperCyt flow cytometry platform for high throughput small molecule discovery. Flow cytometry is recognized for its unique ability to analyze complex and multiplexed target populations in cell and molecular screening where multi-parameter analysis is beneficial.


Add to Calendar ▼2011-06-30 00:00:002011-07-01 00:00:00Europe/LondonScreening Europe - HTS and Compound ManagementSELECTBIOenquiries@selectbiosciences.com